Skip to main content

DnB Asset Management AS

SEC CIK
0001456670
Latest filing
Aug 11, 2026

ABCL holding history

AbCellera Biologics Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings

Shares (Q2 2026)
677,479
Value
$5.32M
% of portfolio
<0.1%
Quarters held
4
Since Q3 2024
Holdings of ABCL by DnB Asset Management AS, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026677,479$5.32M<0.1%+677,479NewHolders
Q4 20250$00.0%−656,208−100.0%Sold outHolders
Q3 2025656,208$3.30M<0.1%+656,208NewHolders
Q1 20250$00.0%−305,579−100.0%Sold outHolders
Q4 2024305,579$895.3K<0.1%+247,342+424.7%AddedHolders
Q3 202458,237$151.4K<0.1%+58,237NewHolders